Biomedical Engineering Reference
In-Depth Information
42. Dechant M, Weisner W, Berger S, Peipp M, Beyer T, Schneider-
Merck T, Lammerts van Bueren JJ, BleekerWK, Parren PW, van
deWinkel JG, Valerius T. (2008) Complement-dependent tumor
cell lysis triggered by combinations of epidermal growth factor
receptor antibodies. Cancer Res. 68, 4998-5003.
43. Holash J, Davis S, Papadopoulos N, Croll SD, Ho L, Russell
M, Boland P, Leidich R, Hylton D, Burova E, Ioffe E, Huang T,
Radziejewski C, Bailey K, Fandl JP, Daly T, Wiegand SJ,
Yancopoulos GD, Rudge JS. (2002) VEGF-Trap: a VEGF
blocker with potent antitumor effects. Proc. Natl. Acad. Sci.
USA 99, 11393-11398.
44. Miller BR, Demarest SJ, Lugovskoy A, Huang F, Wu X,
Snyder WB, Croner LJ, Wang N, Amatucci A, Michaelson
JS, Glaser SM. (2010) Stability engineering of scFvs for the
development of bispecific and multivalent antibodies. Protein
Eng. Des. Sel. 23, 549-557.
Search WWH ::
Custom Search